ImmunoVaccine Technologies Partners With Scancell to Advance DNA Vaccine Delivery
... which is developing therapeutic cancer and
infectious disease vaccines. This research agreement will ... DNA vaccines, especially those for certain
infectious diseases where alternative delivery methods such ... vaccines for the treatment of cancer and
infectious diseases based on its groundbreaking ...
FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business
... with new laboratory testing services for emerging
infectious diseases, developed and, in May 2009, launched ... Diagnostics
Focus Diagnostics, Inc. is an
infectious disease diagnostics company, providing
infectious disease reference laboratory services to ...
MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
... to treat autoimmune disorders, cancer and
infectious diseases, was awarded a $50 million contract in ... 2006 from the National Institute of Allergy and
infectious Diseases, part of the National Institutes of ... biologics for autoimmune disorders, cancer and
infectious diseases. Since its founding in 2000, the ...
Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
... treatment of various forms of cancer and
infectious disease.
Under the terms of the agreement, ... with cancer, neovascular, inflammatory and
infectious disease. The antibodies within the company's ... for the treatment of cancer, inflammation and
infectious disease. For more information, please visit ...
Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
... NVAX ) and the Division of Microbiology and
infectious Diseases (DMID) of the National Institute of Allergy and
infectious Diseases (NIAID), National Institutes of Health ... of the novel H1N1 virus but the VLPs are not
infectious as they lack the genes necessary for replication. ...
The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases
... like to
pool their resources and efforts to fight
infectious diseases through major
research projects, ... needed
to develop new solutions for fighting
infectious diseases. It also represents
a new and ... encouraging collaboration in the fight against
infectious diseases in
developing countries. This includes ...
A Global View: NanoLogix Creates Science Advisory Board
... educator, Dr. Narang has written extensively on
infectious disease and oncology and participated in numerous ... and post-operative complications related to
infectious agents.
Cliff Watts, MD
Dr. Watts has ... and identification of microorganisms present in
infectious and non-infectious human diseases, such as ...
Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
... prulifloxacin Phase 3 trial for the treatment of
infectious diarrhea."
Recent Corporate Highlights
... 3 trial of prulifloxacin for the treatment of
infectious diarrhea. The trial achieved the primary ... the treatment of travelers' diarrhea, a form of
infectious diarrhea. Additional information can be found at ...
Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109
... by the National Institute of Allergy and
infectious Diseases (NIAID), part of the National Institutes ... its global influence, R&D platforms and
infectious disease expertise to proactively address emerging ... States, and worldwide -- to study the causes of
infectious and immune-mediated diseases, and to develop ...
PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
... is sponsored by the National Foundation of
infectious Diseases.
David P. Wright, President and ... funds from the National Institute of Allergy and
infectious Disease, National Institutes of Health.
... Control and Prevention, anthrax is an acute
infectious disease caused by the spore-forming bacterium ...
CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
... of data at the 11th annual National Foundation of
infectious Diseases Conference in Baltimore which ... vaccine technology can induce protection against
infectious disease, induce immunity against HIV, and promote ... new way of maturing dendritic cell vaccines for
infectious diseases such as pandemic flu and cancer.
....
NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza
... Professor and Chief
of the Division of Pediatric
infectious Diseases at the University of Utah
Health Sciences Center. He is very active as an
infectious disease
investigator and in policy. Dr. Pavia ... Microbiology, and Director for the Division of
infectious Diseases
and Immunology, at the St. Louis ...
Intercell Announces FDA Approval of IXIARO(R), a Novel Vaccine to Prevent Japanese Encephalitis
... of Japanese Encephalitis."
JE is a deadly
infectious disease found mainly in Asia. Approximately ... vaccines for the prevention and treatment of
infectious diseases with substantial unmet medical needs. ... In addition, four other products focused on
infectious diseases are in pre-clinical development.
...
Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates
... that assists the immune response in combating
infectious disease through real-time therapeutic filtration of
infectious viruses and immunosuppressive proteins. In HCV ... improve the health of individuals afflicted with
infectious disease and cancer. Aethlon's lead product, the ...
GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2008 Financial Results
... by the National Institutes of Allergy and
infectious Diseases
(NIAID), is the largest ... M.D., Associate Professor, Division
of
infectious Diseases, Department of Medicine, University of
... by HIV-1 (Human Immunodeficiency Virus) and other
infectious agents. GeoVax's AIDS vaccine technology is the ...
Infectious Diseases Company, Sequella, to Present at Upcoming European Conferences
...
infectious Diseases Company Featured on March 9th ... company focused on commercializing products for
infectious diseases of epidemic potential has announced that ... St. Clair 2, 2nd floor, as part of the CNS &
infectious Diseases section of BioSquare 2009 at the Lyon ...
ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
... with the National Institute of Allergy and
infectious Diseases (NIAID) at the National Institutes of ...
"NIAID is a world leader in the study of
infectious and immune-mediated disease, and we look forward ... States, and worldwide-to study the causes of
infectious and immune-mediated diseases, and to develop ...
PharmAthene Presents Data for SparVax(TM) and Valortim(R), a Novel Vaccine and Anti-Toxin for the Prevention and Treatment of Anthrax Infection at the 7th Annual ASM Biodefense Meeting
... and the National Institute of Allergy and
infectious Diseases. This unprecedented collaborative effort ... funds from the National Institute of Allergy and
infectious Disease, National Institutes of Health.
... Control and Prevention, anthrax is an acute
infectious disease caused by the spore-forming bacterium ...
Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
... Grant from the National Institute of Allergy and
infectious Diseases (NIAID), National Institutes of Health ... to develop new antibiotics for important
infectious diseases that impact U.S. public health."
... entities with activity for a broad spectrum of
infectious diseases. Orally bioavailable with excellent ...
Hong Kong Biotech Company, Filligent, Announces CE Certification of Its Revolutionary, Anti-Infective Medical Face Mask, the BioMask
... in
the fight to contain and stop the spread of
infectious respiratory diseases
such as SARS and bird flu. During outbreaks of
infectious disease, the ability
to halt transmission, during ... and advanced protective devices against
infectious or other
diseases. Filligent gives people Health ...
GeoVax Update Provided at the BIO CEO & Investor Conference 2009
... by HIV-1 (Human Immunodeficiency Virus) and other
infectious agents, today announced that Robert McNally, ... funded by the National Institute of Allergy and
infectious Diseases (NIAID), a division of the NIH. GeoVax ... by HIV-1 (Human Immunodeficiency Virus) and other
infectious agents. GeoVax's AIDS vaccine technology is the ...
Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
... company as a Principal Associate and HIV/AIDS and
infectious Disease Advisor. Dr. Osika, a board certified ... with extensive experience working on HIV/AIDS and
infectious disease programs.
Over his 21 year ... programs and policy. Since 2000, he has used his
infectious disease expertise and public health technical ...
Tips from the journals of the American Society for Microbiology
... used a less virulent ancestor to the highly
infectious bubonic plague to develop a potentially safe, ... epidermidis are considered to be the main
infectious agents associated with mastitis, increased ... alternative for the treatment of lactational
infectious mastitis during lactation," say the researchers. ...
Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
... Abbott's position in molecular diagnostics for
infectious disease
CARLSBAD, Calif. and ABBOTT ... biodefense applications, microbial forensics and
infectious disease detection and surveillance, and we ... tool in the detection and surveillance of
infectious diseases in the hospital and clinical settings," ...
Life Sciences Discovery Fund Awards $4.7 Million to Support New Vaccine Program
... startup phase will operate within
the Vaccine and
infectious Disease Institute of Fred Hutchinson ... includes
Battelle Pacific Northwest Division,
infectious Disease Research Institute
(IDRI), PATH, Seattle ... project and
co-director of the Vaccine and
infectious Disease Institute at the Hutchinson
Center. "The ...
Tips from the journals of the American Society for Microbiology
... used a less virulent ancestor to the highly
infectious bubonic plague to develop a potentially safe, ... epidermidis are considered to be the main
infectious agents associated with mastitis, increased ... alternative for the treatment of lactational
infectious mastitis during lactation," say the researchers. ...
Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009
... to
impact millions of people affected by
infectious diseases each year by
creating novel vaccines ... of replication.
Because they resemble actual
infectious particles presenting proteins in
the same ... novel
vaccines to address a broad range of
infectious diseases worldwide using
advanced proprietary ...
GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
... by HIV-1 (Human
Immunodeficiency Virus) and other
infectious agents, today announced its
third quarter 2008 ... M.D., Associate Professor, Division of
infectious Diseases, Department of Medicine, University ... HIV-1 (Human Immunodeficiency Virus) and other
infectious agents.
GeoVax's HIV/AIDS vaccine technology is ...
According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
... was perceived as having the best overall image
in
infectious disease. GlaxoSmithKline, Pfizer and Cubist ... -- one of the largest meetings
attended by
infectious disease specialists -- was held from October ... conducted a brief AlphaPulse(TM) survey of
100
infectious disease specialists to gauge physician reaction ...
GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C
... virus's life cycle," stated Zhi Hong, SVP
of the
infectious Diseases Centre for Excellence in Drug Discovery ... Discovery
dedicated to discovering therapies for
infectious diseases. It is designed
to integrate and better coordinate the progression of
infectious diseases
medicines from therapeutic hypothesis to ...
OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
... 1 site and 44 subjects -- 13 month, Phase IB,
infectious disease study with 12 sites and 24 subjects ... 30 sites and 160 subjects -- 5 month, Phase I,
infectious disease study with 1 site and 15 subjects -- 24 ... 15 site and 30 subjects -- 9 month, Phase I,
infectious disease study with 1 site and 40 subjects
...
Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)
... Ph.D., Senior Director of
Clinical Science and
infectious Diseases at Medarex.
David P. Wright, President ... Control and Prevention, anthrax is
an acute
infectious disease caused by the spore-forming bacterium ... inflammation, autoimmune disorders and
infectious diseases. Medarex
applies its UltiMAb(R) ...
Isis' Ibis Biosciences Subsidiary Highlights the Power of the Ibis T5000 Pathogen Identification and Characterization System at the ICAAC/IDSA Meeting
... and Chemotherapy (ICAAC) and the 46th
Annual
infectious Disease Society of America (IDSA) Meeting to be ... the Ibis T5000 is able to
provide about any
infectious pathogen exceeds existing commercial
capabilities ... infections,
and, in the future, human
infectious disease diagnostics. Ibis develops,
manufactures ...
ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
... industry and academic
experience in the area of
infectious diseases and antimicrobials clinical
research. ... adjunct associate
professor in the division of
infectious diseases, senior research fellow
and steering ... Advisory Boards including the Lancet
infectious Diseases. He
holds a Bachelors of Science in ...
Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
... U.S. National Institutes of Health, The
infectious Disease Research
Institute and Eli Lilly and ... primary members are Eli
Lilly and Company, the
infectious Disease Research Institute (IDRI), and
the National Institute of Allergy and
infectious Diseases (NIAID), part of
the U.S. National ...
Integrated BioTherapeutics Awarded NIAID Contract For Up to $65 Million for Development of a Vaccine against Ebola and Marburg Viruses
... for biodefense and emerging
infectious diseases, announced
they have been awarded a ... from the National
Institute of Allergy and
infectious Diseases (NIAID), part of the National
Institutes ... United States Army Medical
Research Institute of
infectious Diseases (USAMRIID) to develop a subunit
vaccine, ...
The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
... U.S. National Institutes of Health, The
infectious Disease Research
Institute and Eli Lilly and ... primary members are Eli
Lilly and Company, the
infectious Disease Research Institute (IDRI), and
the National Institute of Allergy and
infectious Diseases (NIAID), part of
the U.S. National ...
Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
... contract by the National
Institute of Allergy and
infectious Diseases (NIAID), a part of the US
National ... to carry out Biodefense research in the area
of
infectious disease biomarkers.
Under the contract to be ... Biodefense proteomics research contracts
in
infectious disease with the NIH-NIAID. For more information, ...
Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics
... in
many different areas including biodefense and
infectious disease
surveillance. We are now in the position ... infections,
and, in the future, human
infectious disease diagnostics. Ibis develops,
manufactures ... System, a
revolutionary system to identify
infectious organisms. Isis is a joint
owner of Regulus ...
Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
... intestines
of infected patients regardless of the
infectious agent causing the watery
diarrhoea. Crofelemer ... demonstrated efficacy in clinical trials
in acute
infectious diarrhea of multiple etiologies including ... syndrome ("D-IBS"), Phase 2
-- CRO-ID for acute
infectious diarrhoea (including cholera), Phase 2
-- ...